NCT06032104Active, not recruiting
Feasibility and Colorectal Benefits of Pulses Supplementation
Feasibility of Pulses Supplementation in Healthy Adults: A Feeding Study
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
Beans are a forgotten staple food that shows promise in improving health. The goal of this study is to look at how bean supplementation affects metabolic and bowel health. In the long-term, the investigators believe this research will lead to a better understanding of the impact of beans on bowel health. The investigators also hope that this research study will help us understand ways to improve human diet and prevent colon cancer in the future.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 28 (actual)
- First submitted
- 24 Aug 2023
- Start date
- 27 Oct 2023
- Primary completion date
- Jan 2027
- Lead sponsor
- University of California, Davis
- Diseases
- Obesity
- NCT number
- NCT06032104
What you commit to
- Study type: Interventional
- Participants enrolled: 28
- From 27 Oct 2023 to the primary completion date, Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Inclusions:
- 30-80 years-old
- Overweight or obesity (body mass index ≥ 25 kg/m2)
- Planned for a standard of care colonoscopy for colon cancer screening
- Exclusions:
- Intolerance to a bean or high bean consumer based on a screening survey
- Pregnancy or actively planning to get pregnant
- Any active gastrointestinal disease resulting in disturbed gut function or malabsorption (e.g., chronic diarrhea or inflammatory bowel disease)
- Current or history of any malignancy in the past 10 years.
- Chronic use of opioids, anti-inflammatory drugs, antibiotics, prebiotics, or probiotics within 1 month of study endpoints
- History of a significant systemic condition (e.g., heart disease, chronic kidney disease, liver dysfunction or immune suppression), or abnormal laboratory markers (e.g., abnormal liver enzymes, creatinine, clotting factors, or low platelets count). The severity of the intolerance to fiber/ the medical conditions/lab markers and eligibility will be defined after the careful interview of the patient/review of the medical records by Dr. Hussan)
Age in the registry: 30 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California - Davis Coordinator of this site? Confirm its status | Sacramento | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.